Search

Search Constraints

You searched for: Author/Creator Eggermont, Alexander

Search Results

21. Melanoma and immunotherapy bridge 2015. Issue 1 (July 2016)

22. Melanoma burden by melanoma stage: Assessment through a disease transition model. (January 2016)

23. NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients. (2nd January 2017)

24. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial. Issue 8 (August 2015)

25. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial. Issue 8 (August 2015)

26. Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer. (2nd January 2017)

27. Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review. Issue 12 (December 2019)

28. Response to: Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'. (November 2020)

29. The Porto European Cancer Research Summit 2021. Issue 10 (13th September 2021)

30. Towards a Cancer Mission in Horizon Europe. Issue 11 (31st October 2019)